STAT3 and pancreatic neoplasm: A study by Boreddy et al., 2011 has shown that BITC (5–20 μM) inhibited the phosphorylation of STAT3 in pancreatic cancer cell lines followed by a decrease in VEGF and MMP-2 expression, thus blocking angiogenesis [270].